We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Type
- Cancellation by sponsor (151)
- ARTG (143)
- Cancellation or suspension (4)
- Prescription medicine registration (4)
- Designation or determination (3)
- Face mask cancellation (3)
- Australian public assessment report (AusPar) (2)
- Prescription medicine decision summary (2)
- Face mask non-compliance notice (1)
- Prescription medicine evaluation (1)
Sponsor content
314 result(s) found, displaying 241 to 250
-
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - Glaucoma shunt.
-
Prescription medicine decision summaryTGA decision: Tukysa (tucatinib), in combination with trastuzumab and capecitabine, is approved to treat HER2-positive breast cancer.
-
-
AA-Med Pty Ltd - ReCell Autologous Cell Harvesting Device Cancelled under Section 41GL(d) of the Act
Cancellation by sponsorRequested by AA-Med Pty Ltd -
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - AtriCure® Isolator Synergy™ Access™ Clamp - Epicardial radio-frequency ablation probe; open-surgery.